Hefei Lifeon Pharmaceutical Co., Ltd. (SHE:003020)
China
· Delayed Price · Currency is CNY 22.89
+0.29 (1.28%)
At close: Apr 29, 2026
SHE:003020 Revenue
In the year 2025, Hefei Lifeon Pharmaceutical had annual revenue of 1.55B CNY with 2.33% growth. Hefei Lifeon Pharmaceutical had revenue of 473.12M in the quarter ending December 31, 2025, with 20.27% growth.
Revenue
1.55B
Revenue Growth
+2.33%
P/S Ratio
2.80
Revenue / Employee
1.07M
Employees
1,456
Market Cap
4.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.55B | 35.32M | 2.33% |
| Dec 31, 2024 | 1.52B | -382.30M | -20.11% |
| Dec 31, 2023 | 1.90B | -678.55M | -26.31% |
| Jan 1, 2023 | 2.58B | 306.09M | 13.46% |
| Dec 31, 2021 | 2.27B | 378.96M | 20.01% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pulike Biological Engineering | 1.10B |
| Shanghai Obio Technology (Group) Corp. | 267.70M |
| Boji Medical Technology | 949.94M |
| Beijing Bohui Innovation Biotechnology Group | 812.78M |
| Hinova Pharmaceuticals | 46.50M |
| Assure Tech (Hangzhou) | 453.58M |
| Baolingbao Biology | 2.81B |
| Guanhao Biotech | 387.75M |